Great news for patients suffering from keratoconus – corneal collagen cross-linking, the first therapeutic treatment designed to stop progression of the disease – has been FDA approved. Even better news? It’s now available at Durrie Vision! We’re thrilled to bring this exciting technology to the many patients awaiting treatment. Read more about procedure below.
What is keratoconus?
Keratoconus is a corneal disease where the normally spherical-shaped cornea weakens and progressively thins due to a lack of cross-linkages between corneal fibers, causing a cone-like bulge to develop. Patients affected by the condition may experience one or more of the following symptoms:
- Blurred vision
- Distorted vision
- Light sensitivity
- Difficulty driving at night
- Halo and glare
Corneal cross-linking is a non-invasive procedure that combines the use of ultra-violet (UVA) light and riboflavin (Vitamin B2) eye drops. The treatment shortens and thickens the collagen fibers and creates new collagen crosslinks, resulting in stiffening and strengthening of the cornea.
Benefits of Cross-linking
- Stabilize the cornea and stop disease progression
- Improve corneal curvature
- Preserve visual acuity in most patients, with some experiencing a noticeable improvement
You can learn more about the cross-linking procedure here or call us at 913-491-3330 to schedule a complimentary exam.